Bone-targeted agents in multiple myeloma

por Nishida, Hiroko
Publicado 2018

Rapid Progress in Immunotherapies for Multiple Myeloma: An Updated Comprehensive Review

por Nishida, Hiroko
Publicado 2021

Monoclonal Antibody Therapies in Multiple Myeloma: A Challenge to Develop Novel Targets

por Nishida, Hiroko, Yamada, Taketo
Publicado 2019

Primary isolated bone marrow diffuse large B cell lymphoma with long-term complete remission

por Nishida, Hiroko, Suzuki, Hiroshi, Hori, Masao, Obara, Katsuyuki
Publicado 2018

P1369: HDAC INHIBITION INVOLVES CD26 EXPRESSION ON MULTIPLE MYELOMA CELLS VIA THE C-MYC/SP1-MEDIATED PROMOTER ACTIVATION AND OVERCOMES THERAPEUTIC RESISTANCE BY HUMANIZED ANTIBODY

por Nishida, Hiroko, Suzuki, Reiko, Nakajima, Kiyora, Morimoto, Chikao, Sakamoto, Michiie
Publicado 2023

CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myeloma

por Nishida, Hiroko, Hayashi, Mutsumi, Morimoto, Chikao, Sakamoto, Michiie, Yamada, Taketo
Publicado 2018

A humanized anti-CD26 monoclonal antibody inhibits cell growth of malignant mesothelioma via retarded G2/M cell cycle transition

por Hayashi, Mutsumi, Madokoro, Hiroko, Yamada, Koji, Nishida, Hiroko, Morimoto, Chikao, Sakamoto, Michiie, Yamada, Taketo
Publicado 2016

Novel Antibody-Drug Conjugate with Anti-CD26 Humanized Monoclonal Antibody and Transcription Factor IIH (TFIIH) Inhibitor, Triptolide, Inhibits Tumor Growth via Impairing mRNA Synt...

por Hayashi, Mutsumi, Madokoro, Hiroko, Yamada, Koji, Nishida, Hiroko, Morimoto, Chikao, Sakamoto, Michiie, Yanagawa, Hiroshi, Yamada, Taketo
Publicado 2019

Nuclear Localization of CD26 Induced by a Humanized Monoclonal Antibody Inhibits Tumor Cell Growth by Modulating of POLR2A Transcription

por Yamada, Kohji, Hayashi, Mutsumi, Madokoro, Hiroko, Nishida, Hiroko, Du, Wenlin, Ohnuma, Kei, Sakamoto, Michiie, Morimoto, Chikao, Yamada, Taketo
Publicado 2013